AbstractPeptides derived from the unprocessed N-termini of mouse and bovine prion proteins (mPrPp and bPrPp, respectively), comprising hydrophobic signal sequences followed by charged domains (KKRPKP), function as cell-penetrating peptides (CPPs) with live cells, concomitantly causing toxicity. Using steady-state fluorescence techniques, including calcein leakage and polarization of a membrane probe (diphenylhexatriene, DPH), as well as circular dichroism, we studied the membrane interactions of the peptides with large unilamellar phospholipid vesicles (LUVs), generally with a 30% negative surface charged density, comparing the effects with those of the CPP penetratin (pAntp) and the pore-forming peptide melittin. The prion peptides caused ...
Prion diseases result from a post-translational modification of the physiological prion protein (PrP...
© 2009 American Chemical Society - The final version of record is available at http://pubs.acs.org/j...
AbstractThe key molecular event underlying prion diseases is the conversion of the monomeric and α-h...
AbstractPeptides derived from the unprocessed N-termini of mouse and bovine prion proteins (mPrPp an...
AbstractWe investigated the nuclear localization-like sequence KKRPKP, corresponding to the residues...
© 2008 by the Biophysical SocietyTransmissible spongiform encephalopathies are neurodegenerative dis...
AbstractTransmissible spongiform encephalopathies are neurodegenerative diseases characterized by th...
A synthetic peptide corresponding to the 106-126 amyloidogenic region of the cellular human prion pr...
Prion diseases are characterised by the conversion of the normal a-helical prion protein (PrPc), to ...
AbstractA major hallmark of prion diseases is the cerebral amyloid accumulation of the pathogenic Pr...
Prion diseases are fatal neurodegenerative disorders characterized by the accumulation in the brain ...
This thesis focuses on peptides derived from the Prion, Doppel and Influenza haemagglutinin proteins...
Prion protein (PrP) aggregation arises from the misfolding of the native cellular PrP (PrPC) and is ...
Free to read at publisher's site. Transmissible spongiform encephalopathies are neurodegenerative di...
AbstractThe prion protein (PrP), widely recognized to misfold into the causative agent of the transm...
Prion diseases result from a post-translational modification of the physiological prion protein (PrP...
© 2009 American Chemical Society - The final version of record is available at http://pubs.acs.org/j...
AbstractThe key molecular event underlying prion diseases is the conversion of the monomeric and α-h...
AbstractPeptides derived from the unprocessed N-termini of mouse and bovine prion proteins (mPrPp an...
AbstractWe investigated the nuclear localization-like sequence KKRPKP, corresponding to the residues...
© 2008 by the Biophysical SocietyTransmissible spongiform encephalopathies are neurodegenerative dis...
AbstractTransmissible spongiform encephalopathies are neurodegenerative diseases characterized by th...
A synthetic peptide corresponding to the 106-126 amyloidogenic region of the cellular human prion pr...
Prion diseases are characterised by the conversion of the normal a-helical prion protein (PrPc), to ...
AbstractA major hallmark of prion diseases is the cerebral amyloid accumulation of the pathogenic Pr...
Prion diseases are fatal neurodegenerative disorders characterized by the accumulation in the brain ...
This thesis focuses on peptides derived from the Prion, Doppel and Influenza haemagglutinin proteins...
Prion protein (PrP) aggregation arises from the misfolding of the native cellular PrP (PrPC) and is ...
Free to read at publisher's site. Transmissible spongiform encephalopathies are neurodegenerative di...
AbstractThe prion protein (PrP), widely recognized to misfold into the causative agent of the transm...
Prion diseases result from a post-translational modification of the physiological prion protein (PrP...
© 2009 American Chemical Society - The final version of record is available at http://pubs.acs.org/j...
AbstractThe key molecular event underlying prion diseases is the conversion of the monomeric and α-h...